No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
1. J. Folkman, “Anti-angiogenesis: New concept for therapy of solid tumors,” Ann. Surg. 175, 409–416 (1972).http://dx.doi.org/10.1097/00000658-197203000-00014
2. K. J. Kim, B. Li, J. Winer, M. Armanini, N. Gillett, H. S. Phillips, and N. Ferrara, “Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo,” Nature (London) 362, 841–844 (1993).http://dx.doi.org/10.1038/362841a0
3. M. Paez-Ribes, E. Allen, J. Hudock, T. Takeda, H. Okuyama, F. Vinals, M. Inoue, G. Bergers, D. Hanahan, and O. Casanovas, “Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis,” Cancer Cells 15, 220–231 (2009).http://dx.doi.org/10.1016/j.ccr.2009.01.027
4. F. Azam, S. Mehta, and A. L. Harris, “Mechanisms of resistance to antiangiogenesis therapy,” Eur. J. Cancer 46, 1323–1332 (2010).http://dx.doi.org/10.1016/j.ejca.2010.02.020
5. J. M. Ebos and R. S. Kerbel, “Antiangiogenic therapy: Impact on invasion, disease progression, and metastasis,” Nat. Rev. Clin. Oncol. 8, 210–221 (2011).http://dx.doi.org/10.1038/nrclinonc.2011.21
6. F. Shojaei, “Anti-angiogenesis therapy in cancer: Current challenges and future perspectives,” Cancer Lett. 320, 130–137 (2012).http://dx.doi.org/10.1016/j.canlet.2012.03.008
7. N. T. Fernando, M. Koch, C. Rothrock, L. K. Gollogly, P. A. D’Amore, S. Ryeom, and S. S. Yoon, “Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors,” Clin. Cancer Res. 14, 1529–1539 (2008).http://dx.doi.org/10.1158/1078-0432.CCR-07-4126
8. K. Okuma, H. Yamashita, Y. Niibe, K. Hayakawa, and K. Nakagawa, “Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: A case report,” J. Med. Case Rep. 5, 111 (2011).http://dx.doi.org/10.1186/1752-1947-5-111
9. S. Demaria, B. Ng, M. L. Devitt, J. S. Babb, N. Kawashima, L. Liebes, and S. C. Formenti, “Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated,” Int. J. Radiat. Oncol., Biol., Phys. 58, 862–870 (2004).http://dx.doi.org/10.1016/j.ijrobp.2003.09.012
10. E. F. Stamell, J. D. Wolchok, S. Gnjatic, N. Y. Lee, and I. Brownell, “The abscopal effect associated with a systemic anti-melanoma immune response,” Int. J. Radiat. Oncol., Biol., Phys. (in press).
11. S. E. Cotter, G. P. Dunn, K. M. Collins, D. Sahni, K. A. Zukotynski, J. L. Hansen, D. A. O’Farrell, A. K. Ng, P. M. Devlin, and L. C. Wang, “Abscopal effect in a patient with metastatic Merkel cell carcinoma following radiation therapy: Potential role of induced antitumor immunity,” Arch. Dermatol. 147, 870–872 (2011).http://dx.doi.org/10.1001/archdermatol.2011.176
12. P. B. Lakshmanagowda, L. Viswanath, N. Thimmaiah, L. Dasappa, S. S. Supe, and P. Kallur, “Abscopal effect in a patient with chronic lymphocytic leukemia during radiation therapy: A case report,” Cases J. 2, 204 (2009).http://dx.doi.org/10.1186/1757-1626-2-204
13. M. Nakanishi, M. Chuma, S. Hige, and M. Asaka, “Abscopal effect on hepatocellular carcinoma,” Am. J. Gastroenterol. 103, 1320–1321 (2008).http://dx.doi.org/10.1111/j.1572-0241.2007.01782_13.x
14. V. Celer, “Suppressive effects of ionizing radiation on immunoproductive cells in laboratory mice,” Vet. Med. (Praha) 35, 495–500 (1990).
15. Y. Ina, H. Tanooka, T. Yamada, and K. Sakai, “Suppression of thymic lymphoma induction by life-long low-dose-rate irradiation accompanied by immune activation in C57BL/6 mice,” Radiat. Res. 163, 153–158 (2005).http://dx.doi.org/10.1667/RR3289
16. K. Sakamoto, “Radiobiological basis for cancer therapy by total or half-body irradiation,” Nonlinearity Biol. Toxicol. Med. 2, 293–316 (2004).http://dx.doi.org/10.1080/15401420490900254
17. M. Z. Dewan, A. E. Galloway, N. Kawashima, J. K. Dewyngaert, J. S. Babb, S. C. Formenti, and S. Demaria, “Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody,” Clin. Cancer Res. 15, 5379–5388 (2009).http://dx.doi.org/10.1158/1078-0432.CCR-09-0265
18. N. Wu, S. Z. Jin, X. N. Pan, and S. Z. Liu, “Increase in efficacy of cancer radiotherapy by combination with whole-body low dose irradiation,” Int. J. Radiat. Biol. 84, 201–210 (2008).http://dx.doi.org/10.1080/09553000801902133
19. J. R. Cameron, “A prospective study should be performed to test the hypothesis that an increase in background radiation to residents in the gulf states will increase their longevity. For the proposition,” Med. Phys. 29, 1511–1512 (2002).http://dx.doi.org/10.1118/1.1489045
20. T. D. Luckey, “Nurture with ionizing radiation: A provocative hypothesis,” Nutr. Cancer 34, 1–11 (1999).http://dx.doi.org/10.1207/S15327914NC340101
21. Z. Jaworowski, “The paradigm that failed,” Int. J. Low Radiat. 5, 151–155 (2008).http://dx.doi.org/10.1504/IJLR.2008.019919
22. B. R. Scott, “It's time for a new low-dose-radiation risk assessment paradigm–One that acknowledges hormesis,” Dose Response 6, 333–351 (2008).http://dx.doi.org/10.2203/dose-response.07-005.Scott
23. M. Doss, “Shifting the paradigm in radiation safety,” Dose Response 10, 562–583, (2012).http://dx.doi.org/10.2203/dose-response.11-056.Doss
Article metrics loading...
Full text loading...
Most read this month
Most cited this month